Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
908.5 USD | +2.81% | -1.82% | +15.99% |
May. 03 | Wall Street: weekly results in the green after NFP | CF |
Apr. 30 | Redburn Atlantic Adjusts Price Target on Lam Research to $1,025 From $964, Keeps Buy Rating | MT |
Financials (USD)
Sales 2024 * | 14.87B | Sales 2025 * | 17.66B | Capitalization | 119B |
---|---|---|---|---|---|
Net income 2024 * | 3.77B | Net income 2025 * | 4.62B | EV / Sales 2024 * | 7.93 x |
Net cash position 2024 * | 850M | Net cash position 2025 * | 1.1B | EV / Sales 2025 * | 6.66 x |
P/E ratio 2024 * |
31.8
x | P/E ratio 2025 * |
26.1
x | Employees | 17,200 |
Yield 2024 * |
0.86% | Yield 2025 * |
0.93% | Free-Float | 44.18% |
Latest transcript on Lam Research Corporation
1 day | +2.81% | ||
1 week | -1.82% | ||
Current month | +1.58% | ||
1 month | -4.53% | ||
3 months | +8.33% | ||
6 months | +43.28% | ||
Current year | +15.99% |
Managers | Title | Age | Since |
---|---|---|---|
Timothy Archer
CEO | Chief Executive Officer | 57 | 12-06-03 |
Director of Finance/CFO | 56 | 13-03-10 | |
Robert Hawthorne
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslie Varon
BRD | Director/Board Member | 67 | 19-05-08 |
Chairman | 60 | 11-01-31 | |
Eric Brandt
BRD | Director/Board Member | 62 | 10-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.29% | 2 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 908.5 | +2.81% | 875,385 |
24-05-02 | 883.7 | +1.79% | 724,538 |
24-05-01 | 868.1 | -2.94% | 1,187,771 |
24-04-30 | 894.4 | -3.70% | 973,687 |
24-04-29 | 928.8 | +0.37% | 902,457 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.99% | 119B | |
+22.62% | 354B | |
+38.63% | 106B | |
+10.00% | 19.87B | |
+39.48% | 10.32B | |
+31.33% | 9.88B | |
-2.80% | 7.96B | |
-23.07% | 6.13B | |
+38.66% | 5.48B | |
+29.47% | 4.19B |
- Stock Market
- Equities
- LRCX Stock